Russell Investments Group
ARKG icon

Russell Investments Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Russell Investments Group’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42 Hold
1
– – ﹤0.01% 4307
2026
Q1 		$26 Buy
+1
New +$29 ﹤0.01% 4193
2024
Q3 		– Sell
-13
Closed -$305 – 3693
2024
Q2 		$305 Buy
+13
New +$328 ﹤0.01% 3532

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Russell Investments Group's ARKG Position: Q2 2026 in Review

Russell Investments Group held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 1 share worth $42. The position accounts for ﹤0.01% of the portfolio, ranked #4307.

Russell Investments Group first reported a position in ARKG in Q2 2024 and has held it in 3 quarters since. The position peaked at $305 in Q2 2024. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Russell Investments Group held 1 share of ARK Genomic Revolution ETF worth $42 as of Q2 2026.
  • Russell Investments Group left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #4307 holding.
  • Russell Investments Group first reported a position in ARK Genomic Revolution ETF in Q2 2024 and has held it in 3 quarters since.
  • Russell Investments Group's ARK Genomic Revolution ETF position peaked at $305 in Q2 2024.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.